APA (7th ed.) Citation

Jung, M., Ryu, M., Oh, D. Y., Kang, M., Zang, D. Y., Hwang, I. G., . . . Kang, Y. (2018). Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 21(5), 819-830. https://doi.org/10.1007/s10120-018-0806-1

Chicago Style (17th ed.) Citation

Jung, Minkyu, et al. "Efficacy and Tolerability of Ramucirumab Monotherapy or in Combination with Paclitaxel in Gastric Cancer Patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)." Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 21, no. 5 (2018): 819-830. https://doi.org/10.1007/s10120-018-0806-1.

MLA (9th ed.) Citation

Jung, Minkyu, et al. "Efficacy and Tolerability of Ramucirumab Monotherapy or in Combination with Paclitaxel in Gastric Cancer Patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)." Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 21, no. 5, 2018, pp. 819-830, https://doi.org/10.1007/s10120-018-0806-1.